BioNTech Release: MammaTyper Enables More Precise Prediction Of The Response To Neoadjuvant Chemotherapy Compared To Manual Or Digitalized IHC Post author:Sam Post published:February 14, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Vertex Consolidating R&D Ops in 3 Locations, Shutters Site in Canada March 28, 2017 And It Begins…Looks to Cut $1.2 Billion of NIH R&D Spending This Year March 28, 2017 ColonaryConcepts Sells Its Novel Colonoscopy Preparation Assets To A GI-Focused Specialty Pharma Company May 31, 2017
ColonaryConcepts Sells Its Novel Colonoscopy Preparation Assets To A GI-Focused Specialty Pharma Company May 31, 2017